How big is the Toxicology Drug Screening Market?

The Toxicology Drug Screening Market size is expected to reach USD 14.51 billion in 2024 and grow at a CAGR of 8.77% to reach USD 22.09 billion by 2029. Read More

What is the current Toxicology Drug Screening Market size?

In 2024, the Toxicology Drug Screening Market size is expected to reach USD 14.51 billion. Read More

Who are the key players in Toxicology Drug Screening Market?

Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, Eurofins scientific, Danaher and Laboratory Corporation of America Holdings are the major companies operating in the Toxicology Drug Screening Market. Read More

Which is the fastest growing region in Toxicology Drug Screening Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Toxicology Drug Screening Market?

In 2024, the North America accounts for the largest market share in Toxicology Drug Screening Market. Read More

What years does this Toxicology Drug Screening Market cover, and what was the market size in 2023?

In 2023, the Toxicology Drug Screening Market size was estimated at USD 13.34 billion. The report covers the Toxicology Drug Screening Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Toxicology Drug Screening Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Toxicology Drug Screening Market Share

Statistics for the 2023 & 2024 Toxicology Drug Screening market share, created by Mordor Intelligence™ Industry Reports. Toxicology Drug Screening share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Toxicology Drug Screening Industry

The toxicology drug screening market is moderately competitive, with the presence of a few key players. Some companies currently dominating the market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Eurofins Scientific, Danaher, Laboratory Corporation of America Holdings, BioReliance Inc., Thermo Fisher Scientific Inc., and Enzo Life Sciences Inc.